Author

Maureen A. Zivanovic

Observed names: M A Zivanovic, M. A. Zivanovic, M. A. Zivanovich, M. Zivanovic, M.A. Zivanovic, MAUREEN A. ZIVANOVIC, Maureen Zivanovic, MaureenA. Zivanovic

Institutions: Manchester Academic Health Science Centre, University of Manchester, The Christie NHS Foundation Trust

Observed institutions: Royal Marsden NHS Foundation Trust, Institute of Cancer Research, St George's, University of London, Manchester Academic Health Science Centre, Churchill Hospital, Southampton General Hospital, University Hospital Southampton NHS Foundation Trust, University of Manchester, Royal Marsden Hospital, The Christie Hospital, The Christie NHS Foundation Trust, University of Southampton, Cancer Research UK Manchester Centre

OpenAlex ID: A5110183205

Guidelines for the measurement of glomerular filtration rate using plasma sampling

2004 · John S. Fleming, Maureen A. Zivanovic, et al. · Nuclear Medicine Communications · 306

A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone

1991 · Valerie J. Lewington, Alexander J. McEwan, et al. · European Journal of Cancer and Clinical Oncology · 277

Sr-89 therapy: Strontium kinetics in disseminated carcinoma of the prostate

1986 · G. M. Blake, M. A. Zivanovic, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 251

Strontium-89 chloride for pain palliation in prostatic skeletal malignancy

1991 · A. H. Laing, D. M. Ackery, et al. · British Journal of Radiology · 213

Strontium-89 therapy: measurement of absorbed dose to skeletal metastases.

1988 · G M Blake, M A Zivanovic, et al. · PubMed · 94

Phase 1/2 study of fractionated 131I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy

2008 · Tim M. Illidge, Mike Bayne, et al. · Blood · 87

PDF

Fractionated 90Y-Ibritumomab Tiuxetan Radioimmunotherapy As an Initial Therapy of Follicular Lymphoma: An International Phase II Study in Patients Requiring Treatment According to GELF/BNLI Criteria

2013 · Tim M. Illidge, Sam Mayes, et al. · Journal of Clinical Oncology · 63

PDF

The limitations of the dual radionuclide subtraction technique for the external detection of tumours by radioiodine-labelled antibodies

1983 · R. J. Ott, L. J. Grey, et al. · British Journal of Radiology · 53

A general equation for estimating glomerular filtration rate from a single plasma sample

2005 · John S. Fleming, Linda Persaud, et al. · Nuclear Medicine Communications · 44

Modification by nifedipine of 131I-meta-iodobenzylguanidine kinetics in malignant phaeochromocytoma

1988 · GlenM. Blake, ValerieJ. Lewington, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 35

Strontium-89 radionuclide therapy: a dosimetric study using impulse response function analysis

1987 · G. M. Blake, J. M. Gray, et al. · British Journal of Radiology · 34

Iodine-131-metaiodobenzylguanidine dosimetry in cancer therapy: risk versus benefit.

1996 · M Tristam, A S Alaamer, et al. · PubMed · 32

89Sr radionuclide therapy: Dosimetry and haematological toxicity in two patients with metastasising prostatic carcinoma

1987 · G.M. Blake, M.A. Zivanovic, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 30

Glomerular filtration rate and the kinetics of 123I-metaiodobenzylguanidine

1989 · GlenM. Blake, ValerieJ. Lewington, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 22

Strontium-89 therapy: strontium kinetics and dosimetry in two patients treated for metastasising osteosarcoma

1987 · G. M. Blake, M. A. Zivanovic, et al. · British Journal of Radiology · 20

89Sr Therapy: Strontium plasma clearance in disseminated prostatic carcinoma

1989 · GlenM. Blake, JohnF. Wood, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 19

Short duration immunochemotherapy followed by radioimmunotherapy consolidation is effective and well tolerated in relapsed follicular lymphoma: 5‐year results from a UK National Cancer Research Institute Lymphoma Group study

2016 · Tim M. Illidge, Hayley S. McKenzie, et al. · British Journal of Haematology · 14

Guidelines for the measurement of glomerular filtration rate using plasma sampling

2005 · John Fleming, Maureen Zivanovic, et al. · Nuclear Medicine Communications · 14

Measurements of the strontium plasma clearance rate in patients receiving 89Sr radionuclide therapy

1989 · GlenM. Blake, MaureenA. Zivanovic, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 12

Targeted radiotherapy in the conditioning prior to haematopoietic stem cell transplantation: Results of a phase I trial using an yttrium-90-labelled anti-CD66 murine monoclonal antibody demonstrating consistently high BM uptake

2006 · K.H. Orchard, M. Cooper, et al. · Transplantation and Cellular Therapy · 10

PDF

A retrospective analysis of selective internal radiation therapy (SIRT) with yttrium-90 microspheres in patients with unresectable hepatic malignancies

2010 · A. Omed, J.A.L. Lawrance, et al. · Clinical Radiology · 9

Quality control of slope–intercept measurements of glomerular filtration rate using single-sample estimates

2005 · John S. Fleming, Linda Persaud, et al. · Nuclear Medicine Communications · 8

26. Quality control of two-sample GFR measurements using single-sample estimates

2002 · J. S. Fleming, L. Persaud, et al. · Nuclear Medicine Communications · 8

Abstract 4294: GE152: In vivo detection of tumor apoptosis as a tool for assessment of therapeutic efficacy

2012 · Duncan R. R. Hiscock, Graeme McRobbie, et al. · Cancer Research · 7

Fractionated 90y Ibritumomab Tiuxetan (Zevalin™) Radioimmunotherapy As An Initial Therapy of Follicular Lymphoma – First Results From a Phase II Study in Patients Requiring Treatment According to GELF/BNLI Criteria

2011 · Timothy M Illidge, Ruth Pettengell, et al. · Blood · 7

Works count: 44

Citation count: 1,704

H-index: 16

I10-index: 20